These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 35070418)
1. A systematic review and meta-analysis on the efficacy of Compound Kushen Injection in 3 kinds of digestive tract tumor. Zhang W; Gong W; He X; Wu C; Tu X J Gastrointest Oncol; 2021 Dec; 12(6):2919-2929. PubMed ID: 35070418 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Compound Kushen Injection for Advanced Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials with Trial Sequential Analysis. Wu J; Ma X; Wang X; Zhu G; Wang H; Zhang Y; Li J Integr Cancer Ther; 2024; 23():15347354241258458. PubMed ID: 38853681 [TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of NSCLC ancillary treatment with compound Kushen injection through immunocompetence regulation: A systematic review and meta-analysis. Wang D; Xu Y; Huang T; Peng W; Zhu D; Zhou X; Wu Q Phytomedicine; 2022 Sep; 104():154315. PubMed ID: 35868145 [TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of Compound Kushen Injection with chemoradiotherapy for the outcomes of lung and gastrointestinal cancers: A PRIMSA-compliant meta-analysis. Chen Y; Ma M; Xu F Medicine (Baltimore); 2024 Apr; 103(14):e36758. PubMed ID: 38579051 [TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis of 8 types of traditional Chinese medicine injection combined with chemotherapy in colorectal cancer treatment. Gao W; Zhang K J Cancer Res Clin Oncol; 2023 Sep; 149(12):9823-9838. PubMed ID: 37246189 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis. Yu HB; Hu JQ; Han BJ; Cao HJ; Chen ST; Chen X; Xiong HT; Gao J; Du YY; Zheng HG Front Pharmacol; 2023; 14():1036043. PubMed ID: 36937874 [No Abstract] [Full Text] [Related]
7. Kanglaite injection plus fluorouracil-based chemotherapy on the reduction of adverse effects and improvement of clinical effectiveness in patients with advanced malignant tumors of the digestive tract: A meta-analysis of 20 RCTs following the PRISMA guidelines. Song Q; Zhang J; Wu Q; Li G; Leung EL Medicine (Baltimore); 2020 Apr; 99(17):e19480. PubMed ID: 32332600 [TBL] [Abstract][Full Text] [Related]
8. Clinical Effectiveness and Safety of Chinese Herbal Medicine Compound Kushen Injection as an Add-On Treatment for Breast Cancer: A Systematic Review and Meta-Analysis. Lai BY; Chu AJ; Yu BW; Jia LY; Fan YY; Liu JP; Pei XH Evid Based Complement Alternat Med; 2022; 2022():8118408. PubMed ID: 35047051 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive effect of compound Kushen Injection to chemotherapy for non-small cell lung cancer: An evidence map and overview of systematic reviews. Yu ZY; Peng RY; Han M; Grant S; Yang GY; Liu JP; Cao HJ J Ethnopharmacol; 2021 Dec; 281():114538. PubMed ID: 34418510 [TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis on the use of traditional Chinese medicine compound kushen injection for bone cancer pain. Yanju B; Yang L; Hua B; Hou W; Shi Z; Li W; Li C; Chen C; Liu R; Qin Y; Lv W Support Care Cancer; 2014 Mar; 22(3):825-36. PubMed ID: 24276956 [TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Efficacy and Safety of Compound Kushen Injection Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An Update Systematic Review and Meta-Analysis. Ma X; Li RS; Wang J; Huang YQ; Li PY; Wang J; Su HB; Wang RL; Zhang YM; Liu HH; Zhang CE; Ma ZJ; Wang JB; Zhao YL; Xiao XH Front Pharmacol; 2016; 7():70. PubMed ID: 27065861 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of compound kushen injection for adults with esophageal cancer: A meta-analysis of randomized controlled trials. Pan J; Jia Y; Shi J; Yao R; Guo J J Ethnopharmacol; 2024 Mar; 322():117604. PubMed ID: 38113988 [TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
14. Modified xiaoyao san combined with chemotherapy for breast cancer: A systematic review and meta-analysis of randomized controlled trials. Pan J; Fu S; Zhou Q; Lin D; Chen Q Front Oncol; 2023; 13():1050337. PubMed ID: 37035186 [TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of Xihuang Pill/capsule in adjuvant treatment of breast cancer: A systematic review and meta-analysis of 26 randomized controlled trials. Ge A; Yang K; Deng X; Zhao D; Ge J; Liu L J Ethnopharmacol; 2022 Sep; 295():115357. PubMed ID: 35545184 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Compound Kushen Injection on Patients with Advanced Colon Cancer: A Meta-Analysis of Randomized Controlled Trials. Yu L; Zhou Y; Yang Y; Lu F; Fan Y Evid Based Complement Alternat Med; 2017; 2017():7102514. PubMed ID: 29259647 [TBL] [Abstract][Full Text] [Related]
17. Compound Kushen Injection as an Adjunctive Therapy for the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials. Pu L; Chen WH; Cao LX; Wu KJ; Chen SL; Lin JH; Li CL; Wang SQ; Zhu MM; Zhang YM Evid Based Complement Alternat Med; 2019; 2019():7241927. PubMed ID: 31781277 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of compound kushen injection for treating advanced colorectal cancer: A protocol for a systematic review and meta-analysis. Wu J; Ma X; Wang X; Zhu G; Wang H; Li J Heliyon; 2024 Mar; 10(5):e26981. PubMed ID: 38463847 [TBL] [Abstract][Full Text] [Related]
19. Compound Kushen injection combined with platinum-based chemotherapy for stage III/IV non-small cell lung cancer: A meta-analysis of 37 RCTs following the PRISMA guidelines. Chen H; Yao X; Li T; Lam CW; Zhang R; Zhang H; Wang J; Zhang W; Leung EL; Wu Q J Cancer; 2020; 11(7):1883-1898. PubMed ID: 32194799 [No Abstract] [Full Text] [Related]
20. Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer: A systematic review and meta-analysis. Xu B; Wang X; Wang H; Cao L; Ge Y; Yuan B; Gao R; Li J Front Cell Infect Microbiol; 2022; 12():875225. PubMed ID: 35992176 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]